EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week® 2025 ...

LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland ...

The 2024 Annual Report, 2024 Sustainability Summary, and a recording of the 2024 Full Year Results Webinar held on April 1, 2025 can be viewed by visiting the Company’s Investor Relations webpage.

The health and wellness industry welcomes Mitolyn as its newest product to attract substantial market interest because of its ...

On April 25, 2025, the 66th (Spring 2025) National Pharmaceutical Machinery Exposition & 2025 (Spring) China International ...

Performer 8 is a natural alternative to Viagra (often called the "blue pill"), which is a common medicine for erectile ...

D-Bal is rated 4.8 out of 5. This is one of the highest-rated legal steroids. Most men have reported increased lean muscle ...

Zenflow Spring ® System offers significant and durable benefits three years after placement. The Zenflow Spring is leading the way in establishing a new category of treatment, First-Line ...

Saint Herblain (France), le 26 avril 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’autorité publique de santé en France, l ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

1 Guerrero-Ramos, F., et al. TAR-200 monotherapy in patients with bacillus Calmette-Guérin–unresponsive papillary disease–only high-risk non–muscle-invasive bladder cancer: first results from Cohort 4 ...

In 2025, stubborn belly fat remains one of the most persistent challenges for people across all ages. Burnjaro is rapidly ...